Inventor · disambiguated record
Jochen Pendzialek
Also filed as: PENDZIALEK JOCHEN · PENDZIALEK JOCHEN S
8 granted patents·3 pending applications·51 citations·filing 2014–2025
84Inventor score
Top patents by PatentIndex Score
11 records- 0197US10294300B2Antibody constructs for DLL3 and CD3AMGEN RES MUNICH GMBH·Filed 2016·Granted May 21, 2019·37 cites·16 claims
- 0296US11591396B2Antibody constructs for DLL3 and CD3AMGEN RES MUNICH GMBH·Filed 2020·Granted Feb 28, 2023·5 cites·33 claims
- 0393US10683351B2Antibody constructs for DLL3 and CD3AMGEN RES MUNICH GMBH·Filed 2019·Granted Jun 16, 2020·4 cites·24 claims
- 0486US11447567B2Antibody constructs for FLT3 and CD3AMGEN RES MUNICH GMBH·Filed 2016·Granted Sep 20, 2022·4 cites·18 claims
- 0584US12435139B2Antibody constructs for DLL3 and CD3AMGEN RES MUNICH GMBH·Filed 2022·Granted Oct 7, 2025·0 cites·12 claims
- 0683US2025340639A1Antibody constructs for dll3 and cd3AMGEN RES MUNICH GMBH·Filed 2025·Application pending·0 cites
- 0776US12304952B2Antibody constructs for DLL3 and CD3AMGEN RES MUNICH GMBH·Filed 2021·Granted May 20, 2025·0 cites·16 claims
- 0870US9505849B2Antibody constructs for influenza M2 and CD3AMGEN RES MUNICH GMBH·Filed 2014·Granted Nov 29, 2016·1 cites·20 claims
- 0966US2023272113A1Antibody constructs for flt3 and cd3AMGEN RES MUNICH GMBH·Filed 2022·Application pending·0 cites
- 1053US2025129160A1T cell engager molecules and uses thereofAMGEN RES MUNICH GMBH·Filed 2022·Application pending·0 cites
- 1147US12258404B2Bispecific antibody construct directed to MUC17 and CD3AMGEN INC·Filed 2018·Granted Mar 25, 2025·0 cites·19 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →